QI
JAZZ icon

QS Investors’s Jazz Pharmaceuticals JAZZ Stock Holding History

QS Investors’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$2.01M Buy
+11,287
New +$1.96M 0.02% 352
2020
Q4 		– Sell
-1,760
Closed -$251K – 1222
2020
Q3 		$251K Sell
1,760
-515
-23% -$63.8K ﹤0.01% 992
2020
Q2 		$252K Hold
2,275
– – ﹤0.01% 1080
2020
Q1 		$227K Hold
2,275
– – ﹤0.01% 1030
2019
Q4 		$338K Sell
2,275
-1,000
-31% -$136K ﹤0.01% 1049
2019
Q3 		$420K Buy
3,275
+515
+19% +$69K ﹤0.01% 993
2019
Q2 		$394K Buy
2,760
+1,200
+77% +$161K ﹤0.01% 1036
2019
Q1 		$224K Sell
1,560
-5
-0.3% -$652 ﹤0.01% 1180
2018
Q4 		$194K Hold
1,565
– – ﹤0.01% 1136
2018
Q3 		$263K Hold
1,565
– – ﹤0.01% 1130
2018
Q2 		$270K Buy
1,565
+1,260
+413% +$206K ﹤0.01% 1116
2018
Q1 		$46K Hold
305
– – ﹤0.01% 1486
2017
Q4 		$41K Hold
305
– – ﹤0.01% 1508
2017
Q3 		$45K Hold
305
– – ﹤0.01% 1541
2017
Q2 		$47K Hold
305
– – ﹤0.01% 1539
2017
Q1 		$44K Sell
305
-900
-75% -$117K ﹤0.01% 1561
2016
Q4 		$131K Hold
1,205
– – ﹤0.01% 1218
2016
Q3 		$146K Hold
1,205
– – ﹤0.01% 1160
2016
Q2 		$170K Sell
1,205
-205
-15% -$30.2K ﹤0.01% 1126
2016
Q1 		$184K Buy
1,410
+5
+0.4% +$622 ﹤0.01% 1098
2015
Q4 		$197K Buy
1,405
+5
+0.4% +$693 ﹤0.01% 1091
2015
Q3 		$186K Hold
1,400
– – ﹤0.01% 1086
2015
Q2 		$246K Buy
1,400
+500
+56% +$89.8K ﹤0.01% 1025
2015
Q1 		$156K Hold
900
– – ﹤0.01% 1104
2014
Q4 		$148K Buy
+900
New +$149K ﹤0.01% 1079

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

QS Investors's JAZZ Position: Q2 2021 in Review

QS Investors opened a new position in Jazz Pharmaceuticals (JAZZ) in Q2 2021: 11,287 shares worth $2.01M. The stake represents 0.02% of the portfolio and ranks #352 among its holdings. This is a return to the name: QS Investors previously reported a position in JAZZ as recently as Q3 2020.

QS Investors first reported a position in JAZZ in Q4 2014 and has held it in 25 quarters since. 505 funds tracked by Wall St. Rank hold JAZZ as of Q2 2021.

  • QS Investors held 11,287 shares of Jazz Pharmaceuticals worth $2.01M as of Q2 2021.
  • Jazz Pharmaceuticals was a new QS Investors position in Q2 2021.
  • Jazz Pharmaceuticals made up 0.02% of QS Investors's portfolio in Q2 2021, its #352 holding.
  • QS Investors first reported a position in Jazz Pharmaceuticals in Q4 2014 and has held it in 25 quarters since.
  • 505 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.